Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
Cristan Farmer, Jessica R. Gilbert, Ruin Moaddel, Jomy George, Lilian Adeojo, Jacqueline Lovett, Allison C. Nugent, Bashkim Kadriu, Peixiong Yuan, Todd D. Gould, Lawrence T. Park, Carlos A. Zarate
Topics & Concepts
Treatment-resistant depressionCrossover studyPlaceboKetamineDepression (economics)Randomized controlled trialPsychologyPlacebo responsePharmacologyMedicineClinical trialAnesthesiaPsychiatryMajor depressive disorderInternal medicineCognitionAlternative medicineEconomicsPathologyMacroeconomicsTreatment of Major DepressionTryptophan and brain disordersStress Responses and Cortisol